ArticleScientific reports2025
Stability and control analysis of COVID-19 spread in India using SEIR model.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Analysis of an SIR model: preventive measures, bounded multiplicative random perturbations and optimal control strategies.Scientific reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In this work, we investigate a mathematical model that depicts the dynamics of COVID-19, with an emphasis on the effectiveness of detection and diagnosis procedures as well as the impact of quarantine measures. Using data from May 1 to May 31, 2020, the current study compares three states: Tamil Nadu, Maharashtra, and Andhra Pradesh. A compartmental model has been developed in order to forecast the pandemic's trajectory and devise an effective control strategy. The study then examines the dynamic progression of the pandemic by including important epidemiological factors into a modified SEIR (Susceptible, Exposed, Infectious, Recovered) model. Our method is a thorough analysis of the equilibria of the deterministic mathematical model in question. We use rigorous techniques to find these equilibrium points and then conduct a comprehensive investigation of their stability. Furthermore, an optimum control problem is applied to reduce the illness fatality, taking into account both pharmaceutical and nonpharmaceutical intervention options as control functions. With the aid of Pontryagin's maximal principle, an objective functional has been created and solved in order to minimize the number of infected people and lower the cost of the controls. In terms of the basic reproduction number, the stability of biologically plausible equilibrium points and the qualitative behavior of the model are examined. We found that the disease transmission rate has an effect on reducing the spread of diseases after conducting sensitivity analysis with regard to the basic reproduction number. According to the findings, Tamil Nadu had the lowest reproduction number ([Formula: see text]) and Maharashtra the highest ([Formula: see text]), indicating regional differences in the efficacy of public health initiatives. Furthermore, it has been demonstrated that appropriate control strategies, such as vaccination (Μ), can successfully reduce infection levels and improve recovery rates. In our study compared to the other two states, Tamil Nadu is notable for its quick recovery and decrease in infection rates. In our findings are more dependable and applicable when mathematical analysis and numerical simulations are combined, which also helps to provide a more thorough understanding of the dynamics at work in the COVID-19 environment. This research also offers suggestions for how government agencies, health groups, and legislators can lessen the effects of COVID-19 and distribute resources as efficiently as possible . Finally, we conclude by discussing the optimal control strategy to contain the epidemic.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.